Trial evaluates mortality and intubation rates in acute hypoxemic patients using HFNC and NIV, indicating similar outcomes.
Key Points
This research aims to compare the effectiveness of high flow nasal cannula and non-invasive ventilation in patients with acute hypoxemic respiratory failure.
Randomized trial involving 100 patients with acute hypoxemic respiratory failure.
Participants received either high flow nasal cannula or non-invasive positive pressure ventilation treatments.
Patients monitored for intubation rates, ICU stay duration, and 28-day mortality.
No significant difference in intubation rates between HFNC (50%) and NIPPV (46%) groups.
Average ICU stay was similar between HFNC (8.76 days) and NIPPV (8.6 days).
28-day mortality rates were comparable: 42% in HFNC and 38% in NIPPV.